Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Comprehensive Immunosupressive Drug Coverage for Kidney Transplant Patients Act (HR 2969/S 1454) sought to increase co-sponsors
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
PKD FOUNDATION via PKD FOUNDATION
2011 · third_quarter · Q3
Comprehensive Immunosupressive Drug Coverage for Kidney Transplant Patients Act (HR 2969/S 1454) sought to increase co-sponsors
FY 12 funding for the National Institues of Health (NIH); report language referencing polycystic kidney disease (PKD) to the FY 12 Laborr-Health and Human Services-Educations Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
H.R. 1458/S. 565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act: Met with Ways and Means committee staff; advocacy to increase co-sponsorship of the bill
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Seeking co-sponsorship for and passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Seeking co-sponsorship for and passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Ask for co-sponsorship and support for the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Seeking co-sponsorship for and passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Seeking co-sponsorship for and passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
H.R. 1458/S. 565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act: Met with Ways and Means committee staff; advocacy to increase co-sponsorship of the bill
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Ask for co-sponsorship and support for the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
NIH/NIDDK funding for PKD research and report language with in the FY 2010 Labor-Health and Human Services- Education Appropriations bill; PKD research within the Peer Reviewed Medical Reserach Program(PRMRP) and the Congressionally Directed Medical Research Programs (CDMRP) in the FY 2010 Defense Appropriations bill; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
NIH/NIDDK funding for PKD research and report language with in the FY 2010 Labor-Health and Human Services- Education Appropriations bill; PKD research within the Peer Reviewed Medical Reserach Program(PRMRP) and the Congressionally Directed Medical Research Programs (CDMRP) in the FY 2010 Defense Appropriations bill; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
NIH/NIDDK funding for PKD research and report language with in the FY 2010 Labor-Health and Human Services- Education Appropriations bill; PKD research within the Peer Reviewed Medical Reserach Program(PRMRP) and the Congressionally Directed Medical Research Programs (CDMRP) in the FY 2010 Defense Appropriations bill; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Act (HR 1458/S. 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
NIH/NIDDK funding for PKD research and report language with in the FY 2010 Labor-Health and Human Services- Education Appropriations bill; PKD research within the Peer Reviewed Medical Reserach Program(PRMRP) and the Congressionally Directed Medical Research Programs (CDMRP) in the FY 2010 Defense Appropriations bill; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
NIH/NIDDK funding for PKD research and report language with in the FY 2010 Labor-Health and Human Services- Education Appropriations bill; PKD research within the Peer Reviewed Medical Reserach Program(PRMRP) and the Congressionally Directed Medical Research Programs (CDMRP) in the FY 2010 Defense Appropriations bill; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
NIH/NIDDK funding for PKD research and report language with in the FY 2010 Labor-Health and Human Services- Education Appropriations bill; PKD research within the Peer Reviewed Medical Reserach Program(PRMRP) and the Congressionally Directed Medical Research Programs (CDMRP) in the FY 2010 Defense Appropriations bill; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2009
Client: PKD FOUNDATION · Firm: PKD FOUNDATION
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Act (HR 1458/S. 565)
PKD FOUNDATION via PKD FOUNDATION
2011 · second_quarter · Q2
Request report language to the FY 12 Labor-Health and Human Services- Education Appropriations Bill on polycystic kidney disease
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via PKD FOUNDATION
2011 · first_quarter · Q1
FY 2011 National Institutes of Health (NIH) appropriations; FY 2012 NIH appropriations and report language to the FY 2012 Labor-Health and Human Services-Education Appropriations Act highlights polycystic kidney disease (PKD); Seeking support for including PKD in the FY 2012 Department of Defense Appropriations Act Peer-Reviewed Medical Research Program
Modernizing Our Drug and Diagnostic Evaluation and Regulatory Network (MODDERN) Cures Solution - No bill number yet; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act - No bill number yet; Discussed support for PKD Awareness Week
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via PKD FOUNDATION
2010 · fourth_quarter · 4@
Report language to the FY 2011 Labor-Health and Human Services-Education Appropriations Act supporting PKD research at the National Institute of Diabetes, Digestive and Kidney Disease (NIDDK); support for increasing overall funding for the National Institutes of Health (NIH)
Seeking co-sponsorship for and passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via PKD FOUNDATION
2010 · fourth_quarter · Q4
Seeking co-sponsorship for and passage of the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Report language to the FY 2011 Labor-Health and Human Services-Education Appropriations Act supporting PKD research at the National Institute of Diabetes, Digestive and Kidney Disease (NIDDK); support for increasing overall funding for the National Institutes of Health (NIH)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via PKD FOUNDATION
2010 · third_quarter · Q3
Hosted Congressional Briefing on July 29, 2010 in conjunction with the Congressional Kidney Caucus to discuss PKD Foundation and our public-private partnership with the FDA (Critical Path Institute and C-Disc); Meetings with various HELP Committee and Energy and Commerce Committee staff to brief them on efforts
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via PKD FOUNDATION
2010 · second_quarter · Q2
FY 2011 Defense Appropriations bill: Followed up on requests in the House for establishing a polycystic kidney disease (PKD) research program funded at $5 million in the DoD Congressionally Directed Medical Research Program; FY 2011 Defense Appropriations bill: Filed and followed up on requests in the Senate for keeping PKD listed as a disease eligible to compete for funding under the DoD Peer Reviewed Medical Research Program
H.R. 1458/S. 565 Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act: Met with Ways and Means committee staff; advocacy to increase co-sponsorship of the bill
PKD FOUNDATION via PKD FOUNDATION
2010 · first_quarter · Q1
PKD research in the Department of Defense Peer-Reviewed Medical Reserach Program and the Congressionally Directed Medical Research Programs
Ask for co-sponsorship and support for the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
PKD FOUNDATION via PKD FOUNDATION
2009 · fourth_quarter · Q4
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Act (HR 1458/S. 565)
NIH report language request - FY 2010 Labor-HHS-Education Appropriations Act PKD listed in the Peer Reviewed Medical Reserach Program (PRMRP) in the FY 2010 Defense Appropriations Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via PKD FOUNDATION
2009 · fourth_quarter · RR
NIH/NIDDK funding for PKD research and report language with in the FY 2010 Labor-Health and Human Services- Education Appropriations bill; PKD research within the Peer Reviewed Medical Reserach Program(PRMRP) and the Congressionally Directed Medical Research Programs (CDMRP) in the FY 2010 Defense Appropriations bill; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
NIH/NIDDK funding for PKD research and report language with in the FY 2010 Labor-Health and Human Services- Education Appropriations bill; PKD research within the Peer Reviewed Medical Reserach Program(PRMRP) and the Congressionally Directed Medical Research Programs (CDMRP) in the FY 2010 Defense Appropriations bill; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)
FY 2011 Labor-HHS-Education Appropriations bill: Followed up on requests for report language referencing polycystic kidney disease (PKD); Advocate for overall increase in funding for the National Institues of Health (NIH)
Met with Rep. Beccera's office to discuss potential of Gene Patent legislation. There is no bill yet.; Scheduled meetings and began discussions with House Energy and Commerce committee staff and other personal offices regarding polycystic kidney disease and the Food and Drug Administration's Critical Path Institute
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NIH/NIDDK funding for PKD research and report language with in the FY 2010 Labor-Health and Human Services- Education Appropriations bill; PKD research within the Peer Reviewed Medical Reserach Program(PRMRP) and the Congressionally Directed Medical Research Programs (CDMRP) in the FY 2010 Defense Appropriations bill; Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act (HR 1458/S 565)